CGEM: Cullinan Oncology Inc

CGEM Nouvelles

• Investing 11:11 Taiho Oncology to present updated zipalertinib data in lung cancer
• Seeking Alpha 02:24 Cullinan Therapeutics Stock: Betting On Zipalertinib NDA Catalyst (NASDAQ:CGEM)
• Investing 11:01 InvestingPro’s Fair Value model predicted CGEM’s significant price correction
• Investing 11:02 Cullinan Oncology stock rating reiterated at Buy by Clear Street
• Investing 20:04 Cullinan expands autoimmune focus with new T cell engager license
• Investing 12:32 Taiho Oncology and Cullinan Therapeutics Announce Pivotal REZILIENT1 Phase 1/2 Data Published in the Journal of Clinical Oncology
• Investing 11:28 Cullinan Therapeutics to Host Analyst and Investor Event at 2025 ASCO Annual Meeting and Participate in Jefferies 2025 Global Healthcare Conference
• Investing 21:32 Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025
• Benzinga 12:24 Tesla, Nvidia, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Apple (NASDAQ:AAPL), American Assets Trust (NYSE:AAT)
• Benzinga 12:23 Applied Digital Posts Weak Revenue, Joins Allegro MicroSystems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Applied Digital (NASDAQ:APLD), Allegro Microsystems (NASDAQ:ALGM)